September 2019 in “Journal of Investigative Dermatology” This study found that the clinical severity of hidradenitis suppurativa, evaluated through Hurley staging, VAS, PGA, and SAHS, significantly affects patients' work absenteeism and presenteeism, with presenteeism being more prevalent.
August 2026 in “Dermatology and Therapy” This study in the United Arab Emirates found that alopecia areata significantly impacts patient quality of life and healthcare resource utilization, particularly among those with higher scalp hair loss.
4 citations
,
January 2024 in “Scientific Reports” In this study, researchers examined chronic hepatitis B patients and found that those undergoing interferon therapy reported higher quality of life than those on non-antiviral or nucleoside/nucleotide analogue treatments, despite potential side effects.
3 citations
,
January 2024 in “Preprints.org” This study estimated the economic burden of alopecia areata in Romania for 2022, finding costs of 46.289 million EUR for adult and 1.89 million EUR for pediatric cases.
2 citations
,
July 2023 in “Journal of dermatology” This study reported that alopecia areata imposes a significant personal and national economic burden in Japan, with estimated total costs of 112.7 billion yen due largely to productivity loss.